C. Baud

A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors

J. Schellens, J. Beijnen, S. Howell, 2004, Clinical Cancer Research.